TIAA CREF Investment Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$3.03M Buy
228,235
+62,275
+38% +$827K ﹤0.01% 1759
2018
Q4
$1.31M Sell
165,960
-536
-0.3% -$4.22K ﹤0.01% 2181
2018
Q3
$1.85M Sell
166,496
-45,390
-21% -$503K ﹤0.01% 2161
2018
Q2
$2.84M Buy
+211,886
New +$2.84M ﹤0.01% 1982